Amgen Inc. buy SVB Leerink LLC
Start price
04.02.26
/
50%
€284.45
Target price
04.02.27
€300.22
Performance (%)
15.56%
Price
11.03.26
€326.20
Summary
This prediction is currently active. The prediction currently has a performance of 15.56%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 04.02.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.107% | 0.107% |
| iShares Core DAX® | -2.526% | -5.194% |
| iShares Nasdaq 100 | -0.032% | 1.561% |
| iShares Nikkei 225® | -4.202% | -7.550% |
| iShares S&P 500 | -0.802% | 0.160% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Leerink Partners from $305.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat